Jennifer Doudna’s Innovative Genomics Institute (IGI) has launched an ambitious effort to establish a COVID-19 diagnostic testing laboratory on UC Berkeley campus. The UC Berkeley Tang Center and medical centers around the East Bay will collect patient samples, and will test these samples for SARS-CoV-2, the virus that causes COVID-19. The IGI is a Bay Area research partnership founded by Jennifer Doudna, co-developer of CRISPR. “We are interested in serving the public good,” said Doudna. “The expertise in our institute and in our community can address this public health emergency through the kind of coordination we are uniquely capable of.”

Read more

Source: The Innovative Genomics Institute (IGI)

Picture credit: Innovative Genomics Institute (IGI)

Nicole Verbeeck

Nicole Verbeeck

Nicole Verbeeck is Founder and Editor-in-Chief of Moonshot for Life, covering global health progress. She is also founder of Juneau Cayenne, a creative design, content and technology lab crafting innovative storytelling experiences for clients in healthcare and life sciences worldwide and she is a healthy food chef focusing on prevention of disease.

Share this with your network?

It might help your network to realize the next step of progress!